Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Proguanil hydrochloride | 637-32-1 | 99.2% | 5 MG
SDP

Catalog No. 5000408012
Encompass_Preferred

Proguanil hydrochloride is an antimalarial proagent that is metabolized to its active form, Cycloguanil. It functions as a dihydrofolate reductase (DHFR) inhibitor. While Proguanil itself has weak antimalarial activity, its effectiveness is primarily attributed to Cycloguanil. The combination of Atovaquone and Proguanil shows synergistic activity in vitro, effective against gametocytes and pre-erythrocytic (hepatic) stages of malaria parasites. Additionally, Proguanil, its metabolite 4-chlorophenyl-1-biguanide (CPB), and Cycloguanil reversibly inhibit 5-HT3 receptor responses.

  • Metabolized to active form, Cycloguanil
  • Functions as a dihydrofolate reductase (DHFR) inhibitor
  • Exhibits weak antimalarial activity in vitro, enhanced by Cycloguanil
  • Synergistic with Atovaquone against malaria parasites
  • Inhibits gametocytes and pre-erythrocytic stages
  • Reversibly inhibits 5-HT3 receptor responses

Catalog No. 50-004-08012 Supplier Medchemexpress LLC Supplier No. HYB0806A5MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Proguanil hydrochloride is an antimalarial proagent that is metabolized to its active form, Cycloguanil. It functions as a dihydrofolate reductase (DHFR) inhibitor. While Proguanil itself has weak antimalarial activity, its effectiveness is primarily attributed to Cycloguanil. The combination of Atovaquone and Proguanil shows synergistic activity in vitro, effective against gametocytes and pre-erythrocytic (hepatic) stages of malaria parasites. Additionally, Proguanil, its metabolite 4-chlorophenyl-1-biguanide (CPB), and Cycloguanil reversibly inhibit 5-HT3 receptor responses.

  • Metabolized to active form, Cycloguanil
  • Functions as a dihydrofolate reductase (DHFR) inhibitor
  • Exhibits weak antimalarial activity in vitro, enhanced by Cycloguanil
  • Synergistic with Atovaquone against malaria parasites
  • Inhibits gametocytes and pre-erythrocytic stages
  • Reversibly inhibits 5-HT3 receptor responses

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.